Company / Cost of Revenue
Medline Inc. Cost of Revenue History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$20.9B
FY2025
5-year range
$17.3B / $20.9B
FY2023-FY2025
Trend
+12.9%
vs FY2024
Sector context
#8 of 113
Health Care
What the data says
Among 113 Health Care companies, Medline Inc. is in the bottom 7% for cost of revenue. Increased from $17.3B to $20.9B over the past 2 years.
Based on SEC 10-K filings.
$20.9B in FY2025. Top quartile in the Health Care sector.
Increased from $17.3B to $20.9B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 113This company $20.9B Sector average $11.3B
▼
+85.1% above sector average
Key checks
Key Insights
- In FY2025, cost of revenue increased 12.9% year-over-year.
- Ranks #8 out of 113 companies in the Health Care sector.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.9B | +12.9% |
| FY2024 | $18.5B | +6.8% |
| FY2023 | $17.3B | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026